







On November 12, 2026, CEO Chaejung Heo presented "Tailored Biomaterials through AI-based Medical Information Analysis" as a best practice among participating companies at the final evaluation committee and performance-sharing session of the 2026 AI-based Biomaterial Convergence Product Support Program, held at Courtyard by Marriott Seoul Myeongdong.







